It remains to be explored if the putative involvement of Lys445 in competitive LPL displacement has any bearing on the association of a gain-of-function LPL variant (LPLS447X) with lower plasma triglyceride levels and lower risk of ASCVD (56, 57). The gene discussed is LPL; the disease is atherosclerosis.